Eylea HD: 3-Year Results Show Durable Vision Gains in Wet AMD
Regeneron announced positive three-year results from an extension study of the Phase 3 PULSAR trial for EYLEA HD (aflibercept...
Carmat Aeson® Artificial Heart Achieves 100 Implants
CARMAT announced it has implanted its Aeson® artificial heart in 100 patients, a significant milestone reached with the 99th...
Zivo and U. Delaware Combat Avian Flu
ZIVO Bioscience is initiating a second collaborative study with the University of Delaware to further investigate the potential of...
Koru Medical’s Next-Gen Subcutaneous Infusion System
KORU Medical Systems has partnered with a global pharmaceutical company to develop and seek regulatory clearance for a next-generation...
AI-Powered Cardiac Diagnostics for Underserved Florida Communities
AISAP, a medical technology company specializing in AI-powered point-of-care ultrasound diagnostics, has partnered with Amavita Heart and Vascular Health...
Axena Health and Mayo Clinic Partner to Advance Urinary Incontinence Care
Axena Health and Mayo Clinic have partnered to integrate Mayo Clinic’s overactive bladder (OAB) educational content into Axena Health’s...
Daring Denali Therapeutics MPS II Study Delivers!
Denali Therapeutics announced primary analysis results from a Phase 1/2 study of tividenofusp alfa (DNL310) in 47 participants with...
CytoDyn Shows Statistically Significant Fibrosis Reversal
CytoDyn Inc. announced positive preclinical results for leronlimab, demonstrating a statistically significant reversal of liver fibrosis in three separate...
Wave Life Sciences Initiates Phase 1 Inlight Trial of WVE-007 in Obesity
Wave Life Sciences has initiated a Phase 1 clinical trial, INLIGHT, for WVE-007, a novel RNA interference (RNAi) therapy...
Tonix CD40L MAb Shows Promise in Kidney Transplant Rejection
Tonix Pharmaceuticals announced positive topline results from its Phase 1 single ascending dose trial of TNX-1500, an anti-CD40L monoclonal...